← Back to Search

Metabolic Changes in Asthma

N/A
Recruiting
Led By Fernando Holguin, MD, MPH
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male and female patients, ≥ 18 - 65 years old
Metabolic syndrome diagnosis based on having at least any three of: Triglycerides ≥ 150 mg/dl; High-density lipoproteins (HDL) cholesterol ≤ 50 mg/dl for women and ≤ 40 mg/dl for men; Fasting blood glucose ≥ 100 mg/dl; Waist circumference > 40 inches males and > 35 inches females; Previously diagnosed hypertension or on antihypertensive medication; Blood pressure greater than 130/85 on two consecutive measurements (Specific to Metabolic Syndrome Group)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 6 months of collection
Awards & highlights

Study Summary

This trial is testing whether obesity and metabolic syndrome have a combined effect on airway nitric oxide metabolism.

Who is the study for?
This trial is for adults aged 18-65 with asthma, obesity (BMI ≥ 30), and possibly metabolic syndrome. Asthmatics must have had a diagnosis for over 6 months, non-smokers for at least a year, and certain lung function criteria. People with recent respiratory issues, hospital visits due to asthma, or on specific medications like corticosteroids or statins cannot join.Check my eligibility
What is being tested?
The study aims to understand the relationship between obesity/metabolic syndrome and airway nitric oxide in asthmatics by sampling cells from the bronchial airway epithelium and nasal epithelium through bronchoscopy.See study design
What are the potential side effects?
Bronchoscopy may cause discomfort in the throat, coughing, gagging during the procedure; there's also a small risk of bleeding or infection where cells are sampled.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I have been diagnosed with metabolic syndrome.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 6 months of collection
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 6 months of collection for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measurement of L-arginine-NO biosynthesis pathways in the airway epithelium in obese and non-asthmatics.
Measurement of oxidative stress in the airway epithelium in obese and non-asthmatics.
Secondary outcome measures
Measurement of mitochondrial density
Measurement of mitochondrial structural differences.
Patterns of Gene expression found in the nasal epithelium.

Trial Design

4Treatment groups
Experimental Treatment
Group I: Obese non-asthmaticsExperimental Treatment1 Intervention
BMI >/= 30
Group II: Obese AstmaticsExperimental Treatment1 Intervention
BMI >/= 30 and with metabolic syndrome
Group III: Obese AsthmaticsExperimental Treatment1 Intervention
BMI >/= 30 and without metabolic syndrome
Group IV: Non - obese asthmaticsExperimental Treatment1 Intervention
BMI: lean > 20; Normal >/= 20 to <25; overweight </= 25 to < 30;

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,738 Previous Clinical Trials
2,149,476 Total Patients Enrolled
20 Trials studying Asthma
2,935 Patients Enrolled for Asthma
National Jewish HealthOTHER
140 Previous Clinical Trials
316,186 Total Patients Enrolled
23 Trials studying Asthma
17,734 Patients Enrolled for Asthma
Fernando Holguin, MD, MPHPrincipal InvestigatorUniversity of Colorado Denver, Anschutz Medical Campus
7 Previous Clinical Trials
619 Total Patients Enrolled
7 Trials studying Asthma
619 Patients Enrolled for Asthma

Media Library

Obese Astmatics Clinical Trial Eligibility Overview. Trial Name: NCT03215836 — N/A
Asthma Research Study Groups: Obese Astmatics, Obese non-asthmatics, Non - obese asthmatics, Obese Asthmatics
Asthma Clinical Trial 2023: Obese Astmatics Highlights & Side Effects. Trial Name: NCT03215836 — N/A
Obese Astmatics 2023 Treatment Timeline for Medical Study. Trial Name: NCT03215836 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for enrolment in this experiment currently available?

"As evidenced on clinicaltrials.gov, this medical study is actively necessitating participants who meet the inclusion criteria; it was first opened to enrollment in August 2017 and has most recently been updated in September 2021."

Answered by AI

Is this research endeavor enrolling individuals aged 20 or over?

"This experiment is enrolling patients of legal age (18+) and below the age of 65."

Answered by AI

How many participants are being admitted to this research trial?

"Affirmative. According to information on the clinicaltrials.gov website, this medical trial is actively recruiting participants for their research. Originally posted on August 10th 2017 and last updated September 17th 2021, 50 volunteers are needed from one site."

Answered by AI

Is it feasible for me to participate in this experiment?

"This medical trial, open to participants aged 18-65 who have obesity, is recruiting up to 50 individuals meeting the following criteria: on blood pressure treatment and diet/exercise only regimen for diabetes; male or female with a history of smoking fewer than 10 pack years in their lifetime and abstaining from tobacco over the last 12 months; any race/ethnicity diagnosed with asthma at least 6 months prior."

Answered by AI
~15 spots leftby Mar 2027